Bristol-Myers wins FDA nod for novel antipsychotic
Wall Street Breakfast
00:00
FDA Approval of New Antipsychotic and Major Telecom Merger in Progress
This chapter highlights recent investment developments, including the FDA's approval of a new antipsychotic drug that boosted its pharmaceutical company's stock. It also explores a potential telecommunications merger that could reshape the U.S. pay TV landscape, despite past legal challenges.
Transcript
Play full episode
